ArticleAmerican journal of translational research2021

Identification and validation of significant gene mutations to predict clinical benefit of immune checkpoint inhibitors in lung adenocarcinoma.

Ying Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.